Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

3.51
-0.1800-4.88%
Post-market: 3.50-0.0100-0.28%19:59 EDT
Volume:8.49M
Turnover:30.53M
Market Cap:1.45B
PE:-3.21
High:3.72
Open:3.66
Low:3.51
Close:3.69
52wk High:5.63
52wk Low:1.64
Shares:411.96M
Float Shares:339.00M
Volume Ratio:0.68
T/O Rate:2.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0941
EPS(LYR):-1.0941
ROE:-55.50%
ROA:-27.30%
PB:2.07
PE(LYR):-3.21

Loading ...

May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 19, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Dec 27, 2023

Major Issues Report

Form 8-K - Current report